American Origin Unverified
This profile is unclaimed and has not been independently reviewed.
Claim & get verified
AL
ALLURION TECHNOLOGIES, INC.
$0.74
-15.02%
OTC: ALUR · 15-min delayed
$15.2MRevenue · FY2025
-$28.8MNet income
ALUROTC
About ALLURION TECHNOLOGIES, INC.
ALLURION TECHNOLOGIES INC
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Reported figures
Financial summary
- Revenue FY2025
- $15.2M
- Net income
- -$28.8M
- Total assets
- $15.8M
- Gross margin
- 62.8%
- Operating margin
- -198.0%
- Net margin
- -188.8%
Source: SEC EDGAR · updated Jun 8, 2026
Multi-year
Revenue & profit trend
FY2023
FY2024
FY2025
Revenue Net income
FY 2025
Financial statements
Income statement
- Revenue
- $15.2M
- Cost of revenue
- $5.7M
- Gross profit
- $9.6M
- Operating expenses
- $39.7M
- Operating income
- -$30.2M
- Income tax
- $74.0K
- Net income
- -$28.8M
- EPS (basic)
- $-3.81
- EPS (diluted)
- $-3.81
Balance sheet
- Total assets
- $15.8M
- Current assets
- $12.8M
- Total liabilities
- $93.0M
- Current liabilities
- $38.4M
- Shareholders’ equity
- -$77.2M
Cash flow
- Operating cash flow
- -$28.9M
- Investing cash flow
- $10.0M
- Financing cash flow
- $19.0M
- Net cash flow
- $0
Statements via Polygon.io (SEC filings)
- EPS (diluted)
- $-3.81
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Market data by Polygon.io · prices are 15-minute delayed
Auto-generated
At a glance
- Reported a net loss of $28.8M in FY2025.
- Revenue declined 72% from FY2023 to FY2025.
- Gross margin of 62.8%, net margin -188.8%.
- Trading 77% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review ALLURION TECHNOLOGIES, INC..
Write a review
Newsroom
News about ALLURION TECHNOLOGIES, INC.
Bariatric Surgery Market to Reach USD 3.34 Billion by 2032, Fueled by Rising Obesity Rates and Advances in Minimally Invasive Procedures | SNS Insider
October's 4 Best Penny Stocks: High-Risk, High-Reward Picks
Allurion (ALUR) Unveils Positive Data for Its Balloon Therapy
Allurion Technologies, Inc. (ALUR) Loses -38.66% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Dow Dips Over 200 Points; RPM International Shares Fall After Q3 Results
Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
News & sentiment via Polygon.io
Explore
Browse all →
